Illumina Inc ILMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:10 PM EDT

115.01UNCH (UNCH)

Volume

53,582

115.01

-0.57 (-0.49%)

Volume

1,188,390

52 week range

89.00 - 213.91

Open118.25
Day High118.28
Day Low113.13
Prev Close115.58
52 Week High213.91
52 Week High Date05/24/23
52 Week Low89.00
52 Week Low Date11/10/23

Key Stats

Market Cap18.321B
Shares Out159.30M
10 Day Average Volume2.01M
Dividend-
Dividend Yield-
Beta1.23
YTD % Change-17.4

KEY STATS

Open118.25
Day High118.28
Day Low113.13
Prev Close115.58
52 Week High213.91
52 Week High Date05/24/23
52 Week Low89.00
52 Week Low Date11/10/23
Market Cap18.321B
Shares Out159.30M
10 Day Average Volume2.01M
Dividend-
Dividend Yield-
Beta1.23
YTD % Change-17.4

RATIOS/PROFITABILITY

EPS (TTM)-8.15
P/E (TTM)-14.11
Fwd P/E (NTM)167.17
EBITDA (TTM)348.00M
ROE (TTM)-20.75%
Revenue (TTM)4.493B
Gross Margin (TTM)61.36%
Net Margin (TTM)-28.69%
Debt To Equity (MRQ)25.99%

EVENTS

Earnings Date08/07/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Illumina Inc

Lightning Round: Illumina is a good company that's poorly run, says Jim CramerApril 29, 2024CNBC.com
Cramer's Lightning Round: Palo Alto Networks is a buyApril 29, 2024CNBC.com
When Tesla shares rise — these 7 stocks have tended to rise too recentlyApril 24, 2024CNBC.com

Content From Our Affiliates

Early notable gainers among liquid option names on May 14thMay 14, 2024TipRanks
TD Cowen Sticks to Its Hold Rating for Illumina (ILMN)May 14, 2024TipRanks
QQQ ETF Update, 5/14/2024 May 14, 2024TipRanks
QQQ ETF Update, 5/10/2024 May 10, 2024TipRanks
Analysts’ Top Healthcare Picks: Ultragenyx Pharmaceutical (RARE), Illumina (ILMN)May 8, 2024TipRanks

Profile

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated...

Stephen Macmillan

Independent Non-Executive Chairman of the Board

Jacob Thaysen Ph.D.

Chief Executive Officer, Director

Ankur Dhingra

Chief Financial Officer

Steve Barnard

Chief Technology Officer

Carissa Rollins

Chief Information Officer

Address

5200 Illumina Way

San Diego, CA

92122-4616

United States

https://www.illumina.com

Top Peers

SYMBOL	LAST	CHG	%CHG
CRL Charles River Laboratories International Inc	232.56	-0.26	-0.11%
INCY Incyte Corp	57.05	UNCH	UNCH
GMAB Genmab A/S	30.22	+0.69	+2.34%
BNTX Biontech SE	92.20	-0.08	-0.09%
ALNY Alnylam Pharmaceuticals Inc	147.40	-0.49	-0.33%